series-b
Stage
About
Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics targeting substance use and central nervous system disorders, including treatments for opioid withdrawal and seizure disorders.
Explore Proniras's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.